Auryxia recalls

Auryxia products have been recalled 4 times, most recently on 2 Jun 2021. The recalling company is usually Keryx Biopharmaceuticals. The most common reason is manufacturing (cgmp) deviations.

Total recalls4since 2018

Last 12 months0reported

Class I00% of total

Ongoing0latest 2 Jun 2021

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 3 75%Class III 1 25%

Why auryxia is recalled

Manufacturing (CGMP) Deviations375%
Other Reasons125%

Companies

By year

2021125%
2020250%
2018125%

All auryxia recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
2 Jun 2021Drug	CLASS II	Auryxia (ferric citrate) tablets 210 mg* recalled by Cardinal HealthAuryxia	Cardinal Health	Manufacturing (CGMP) Deviations	FL, GA, SC
30 Dec 2020Drug	CLASS II	Auryxia (ferric citrate) tablets, 210 mg recalled by Akebia TherapeuticsAuryxia	Akebia Therapeutics	Manufacturing (CGMP) Deviations	Nationwide
22 Jul 2020Drug	CLASS II	Auryxia (ferric citrate) tablets 210 mg recalledAuryxia	Keryx Biopharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
3 Jan 2018Drug	CLASS III	Auryxia (ferric citrate) tablets, 210 mg recalledAuryxia	Keryx Biopharmaceuticals	Other	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.